Underexpression of Cyclin-Dependent Kinase (CDK) Inhibitors in Cervical Carcinoma

Author： Kim Y.T.   Cho N.H.   Park S.W.   Kim J.W.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.71, Iss.1, 1998-10, pp. : 38-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Selective Cyclin-Dependent Kinase 4 Inhibitors for Antineoplastic Therapies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 5, 2017-04 ,pp. : 646-657

Bentham Science Publishers

Access to resources Recommend Favorite

Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma

By                

Molecular Medicine Reports, Vol. 12, Iss. 5, 2015-01 ,pp. : 6501-6508

Spandidos Publications

Access to resources Recommend Favorite

X-Ray Crystallographic Studies of CDK2, a Basis for Cyclin-Dependent Kinase Inhibitor Design in Anti-Cancer Drug Research

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 1, 2003-01 ,pp. : 15-23

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth

By      

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 903-910

Spandidos Publications

Access to resources Recommend Favorite

Effect of cyclin-dependent kinase 7 silencing on cisplatin sensitivity in endometrial carcinoma cells

By  

Molecular Medicine Reports, Vol. 11, Iss. 3, 2015-01 ,pp. : 1745-1751

Spandidos Publications

Access to resources Recommend Favorite